Cencora, Inc.
CORAPI behind this page
COR Q1 2026 request
Playground key active
/api/financials?ticker=COR&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Alliance Healthcare · International Healthcare Solutions | 6,530,697 | 5,999,200 | +8.9% |
| Animal Health · Corporate Non Segment | 1,471,317 | 1,379,985 | +6.6% |
| Other Healthcare Solutions · International Healthcare Solutions | 1,093,276 | 959,695 | +13.9% |
| Other non-strategic businesses · Corporate Non Segment | 657,630 | 622,470 | +5.6% |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 7,623,973 | 6,958,895 | +9.6% |
| U. S. Healthcare Solutions · Operating Segments | 76,211,825 | 72,555,294 | +5.0% |
Show — breakouts |
|||
| Revenue | 85,932,016 | 81,487,060 | +5.5% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 2,128,947 | 2,002,455 | +6.3% |
| Intersegment Elimination | -32,729 | -29,584 | -10.6% |
| Cost of Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 6,834,551 | 6,194,653 | +10.3% |
| U. S. Healthcare Solutions · Operating Segments | 74,328,262 | 71,100,485 | +4.5% |
Show — breakouts |
|||
| Cost of Revenue | 82,859,945 | 78,929,022 | +5.0% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 1,804,466 | 1,684,783 | +7.1% |
| Intersegment Elimination | -28,509 | -27,860 | -2.3% |
| Operating Segments | 82,938,770 | 78,952,061 | +5.0% |
| Gross Profit (Q) | — | — | — |
Show — breakouts |
|||
| Gross Profit | 3,072,071 | 2,558,038 | +20.1% |
| Selling, General & Administrative (Q) | — | — | — |
Show — breakouts |
|||
| Selling, General & Administrative | 1,795,289 | 1,472,055 | +22.0% |
| Depreciation Nonproduction (Q) | — | — | — |
Show — breakouts |
|||
| Depreciation Nonproduction | 134,288 | 112,712 | +19.1% |
| Amortization Of Intangible Assets (Q) | — | — | — |
Show — breakouts |
|||
| Amortization Of Intangible Assets | 126,113 | 165,780 | -23.9% |
| Litigation Settlement Expense (Q) | — | — | — |
Show — breakouts |
|||
| Litigation Settlement Expense | -86,151 | 16,765 | -613.9% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -86,151 | 16,765 | -613.9% |
| Business Combination Acquisition Related Costs (Q) | — | — | — |
Show — breakouts |
|||
| Business Combination Acquisition Related Costs | 78,419 | 38,712 | +102.6% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 78,419 | 38,712 | +102.6% |
Show Business Acquisition breakouts |
|||
| RCA · Equity units | 42.1 | — | — |
| Restructuring Charges (Q) | — | — | — |
Show — breakouts |
|||
| Restructuring Charges | 14,166 | 45,760 | -69.0% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 14,166 | 45,760 | -69.0% |
| Asset Impairment Charges (Q) | — | — | — |
Show — breakouts |
|||
| Asset Impairment Charges | 249,498 | — | — |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 249,498 | — | — |
| Operating Income (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 142,156 | 165,180 | -13.9% |
| U. S. Healthcare Solutions · Operating Segments | 831,330 | 686,925 | +21.0% |
Show — breakouts |
|||
| Operating Income | 760,449 | 706,254 | +7.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 91,417 | 97,329 | -6.1% |
| Intersegment Elimination | -2,189 | -126 | -1637.3% |
| Operating Segments | 1,062,714 | 949,308 | +11.9% |
| Non-Operating Income (Expense) (Q) | — | — | — |
Show — breakouts |
|||
| Non-Operating Income (Expense) | -20,600 | 57,874 | -135.6% |
| Interest Income Expense Nonoperating Net (Q) | — | — | — |
Show — breakouts |
|||
| Interest Income Expense Nonoperating Net | 72,409 | 27,933 | +159.2% |
| Income Before Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Income Before Taxes | 708,640 | 620,447 | +14.2% |
| Income Tax Expense (Benefit) (Q) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 142,514 | 126,728 | +12.5% |
| Net Income (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 6,479 | 5,119 | +26.6% |
| Retained Earnings | 559,647 | 488,600 | +14.5% |
Show — breakouts |
|||
| Net Income | 566,126 | 493,719 | +14.7% |
| Net Income Loss Attributable To Noncontrolling Interest (Q) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | -6,479 | -5,119 | -26.6% |
| Net Income (Q) | — | — | — |
Show — breakouts |
|||
| Net Income | 559,647 | 488,600 | +14.5% |
| EPS (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 2.88 | 2.52 | +14.3% |
| EPS (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 2.87 | 2.5 | +14.8% |
| Wtd Avg Shares (Basic) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | 194,219 | 193,758 | +0.2% |
| Wtd Avg Shares (Diluted) (Q) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 195,319 | 195,188 | +0.1% |
| Common Stock Dividends Per Share Declared (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock Dividends Per Share Declared | 0.6 | 0.55 | +9.1% |
| Operating Expenses (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 647,266 | 599,062 | +8.0% |
| U. S. Healthcare Solutions · Operating Segments | 1,052,233 | 767,884 | +37.0% |
Show — breakouts |
|||
| Operating Expenses | 1,930,532 | 1,585,691 | +21.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 233,064 | 220,343 | +5.8% |
| Intersegment Elimination | -2,031 | -1,598 | -27.1% |
| Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 556,605 | 78,094 | +612.7% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 1,753,122 | 3,224,260 | -45.6% |
| Accounts Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Receivable | 25,979,920 | — | — |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 24,078,494 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 313,575 | — | — |
| Contract With Customer Asset Gross Current (Q) | — | — | — |
Show — breakouts |
|||
| Contract With Customer Asset Gross Current | 1,661,822 | 1,192,707 | +39.3% |
| Prepaid Expenses & Other Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Prepaid Expenses & Other Current Assets | 678,218 | 515,923 | +31.5% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 54,151,576 | 49,986,634 | +8.3% |
| Non-Current Assets | |||
| Property, Plant & Equipment (Q) | — | — | — |
Show — breakouts |
|||
| Property, Plant & Equipment | 2,450,799 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 69,570 | — | — |
| Goodwill (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 2,648,231 | — | — |
| U. S. Healthcare Solutions · Operating Segments | 9,826,495 | — | — |
Show — breakouts |
|||
| Goodwill | 13,730,761 | — | — |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 1,256,035 | — | — |
| Deferred Tax Assets (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Assets | 206,821 | 219,417 | -5.7% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 4,142,530 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 96,671 | — | — |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 78,361,214 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 918,693 | — | — |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 3,328,642 | 3,333,662 | -0.2% |
| Trade names and other | 333,085 | 331,549 | +0.5% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets Net Excluding Goodwill | 3,678,727 | 3,682,211 | -0.1% |
| Current Liabilities | |||
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 56,063,820 | 49,910,853 | +12.3% |
| Accrued Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Liabilities | 2,726,043 | 2,385,026 | +14.3% |
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 342,276 | 2,213,226 | -84.5% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 59,132,139 | 54,509,105 | +8.5% |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| Alliance Healthcare debt | 70,507 | 11,293 | +524.3% |
| Multi-currency revolving credit facility due in 2030 | 220,000 | 1,665,900 | -86.8% |
| Nonrecourse debt | 51,769 | 36,124 | +43.3% |
| Non-Current Liabilities | |||
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 7,579,459 | 5,935,321 | +27.7% |
| Accrued Income Taxes Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Accrued Income Taxes Noncurrent | 351,490 | 303,433 | +15.8% |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 1,635,670 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 11,386 | — | — |
| Litigation Reserve Noncurrent (Q) | — | — | — |
Show — breakouts |
|||
| Litigation Reserve Noncurrent | 3,868,883 | 4,296,902 | -10.0% |
Show Litigation Case breakouts |
|||
| Opioid Lawsuits and Investigations | 3.9 | 4.3 | -9.3% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 3,697,605 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 72,331 | — | — |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| $1,000,000, 2.700% senior notes due 2031 | 994,118 | — | — |
| $500,000, 2.800% senior notes due 2030 | 497,327 | — | — |
| $500,000, 4.250% senior notes due 2045 | 495,846 | — | — |
| $500,000, 4.300% senior notes due 2047 | 494,154 | — | — |
| $500,000, 4.625% senior notes due 2027 | 497,615 | — | — |
| $500,000, 5.125% senior notes due 2034 | 495,251 | — | — |
| $600,000, 4.850% senior notes due 2029 | 596,804 | — | — |
| $700,000, 5.150% senior notes due 2035 | 695,048 | — | — |
| $750,000, 3.450% senior notes due 2027 | 748,360 | — | — |
| Alliance Healthcare debt | 70,507 | — | — |
| Multi-currency revolving credit facility due in 2030 | 220,000 | — | — |
| Nonrecourse debt | 150,541 | — | — |
| Term loan due in 2027 | 799,177 | — | — |
| €500,000, 2.875% senior notes due 2028 | 584,652 | — | — |
| €500,000, 3.625% senior notes due 2032 | 582,335 | — | — |
Show — breakouts |
|||
| Long-Term Debt | 7,921,735 | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 98,772 | — | — |
| Total Liabilities (Q) | — | — | — |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 712,319 | — | — |
| Other Liabilities | |||
| Minority Interest (Q) | — | — | — |
Show — breakouts |
|||
| Minority Interest | 187,640 | 135,322 | +38.7% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 2,983 | 2,971 | +0.4% |
| Additional Paid In Capital Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Additional Paid In Capital Common Stock | 6,273,322 | 6,106,291 | +2.7% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | 6,967,358 | 5,794,851 | +20.2% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -905,078 | -1,399,624 | +35.3% |
| Treasury Stock Common Value (Q) | — | — | — |
Show — breakouts |
|||
| Treasury Stock Common Value | -10,430,257 | -10,277,909 | -1.5% |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | 1,908,328 | 226,580 | +742.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -905,078 | -1,399,624 | +35.3% |
| Additional Paid In Capital | 6,273,322 | 6,106,291 | +2.7% |
| Common Stock | 2,983 | 2,971 | +0.4% |
| Noncontrolling Interest | 187,640 | 135,322 | +38.7% |
| Retained Earnings | 6,967,358 | 5,794,851 | +20.2% |
| Treasury Stock Common | -10,430,257 | -10,277,909 | -1.5% |
Show — breakouts |
|||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2,095,968 | 361,902 | +479.2% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 78,361,214 | 69,054,314 | +13.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation (Q) | — | — | — |
Show — breakouts |
|||
| Depreciation | 135,247 | 113,629 | +19.0% |
| Adjustment For Amortization (Q) | — | — | — |
Show — breakouts |
|||
| Adjustment For Amortization | 129,024 | 167,843 | -23.1% |
| Provision For Doubtful Accounts (Q) | — | — | — |
Show — breakouts |
|||
| Provision For Doubtful Accounts | 13 | 3,871 | -99.7% |
| Deferred Income Taxes (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | 14,362 | -5,077 | +382.9% |
| Stock-Based Compensation (Q) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 66,054 | 70,384 | -6.2% |
| Inventory L I F O Reserve Period Charge (Q) | — | — | — |
Show — breakouts |
|||
| Inventory L I F O Reserve Period Charge | -77,562 | -7,324 | -959.0% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | -77,562 | -7,324 | -959.0% |
| Inflationary Accounting Impact (Q) | — | — | — |
Show — breakouts |
|||
| Inflationary Accounting Impact | 8,723 | 7,666 | +13.8% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 (Q) | — | — | — |
Show — breakouts |
|||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | 42,137 | — | — |
| Equity Investment Remeasurement Gain Loss (Q) | — | — | — |
Show — breakouts |
|||
| Equity Investment Remeasurement Gain Loss | -10,501 | -3,480 | -201.8% |
| Gain Loss On Sale Of Other Assets (Q) | — | — | — |
Show — breakouts |
|||
| Gain Loss On Sale Of Other Assets | -35,816 | — | — |
| Other Non-Cash Items (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Cash Items | 6,726 | 7,047 | -4.6% |
| Change in Accounts Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Receivable | -830,752 | -974,256 | +14.7% |
| Change in Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | -3,519,839 | -1,655,165 | -112.7% |
| Change in Prepaid & Other Assets (Q) | — | — | — |
Show — breakouts |
|||
| Change in Prepaid & Other Assets | -14,386 | 70,310 | -120.5% |
| Change in Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Payable | 1,307,868 | -654,165 | +299.9% |
| Increase Decrease In Accrued Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Accrued Liabilities | -328,365 | -338,130 | +2.9% |
| Increase Decrease In Income Taxes Payable And Other Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Increase Decrease In Income Taxes Payable And Other Liabilities | -13,726 | -51,193 | +73.2% |
| Net Cash from Operations (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | -2,305,169 | -2,718,782 | +15.2% |
| Depreciation & Amortization (Q) | — | — | — |
Show Business Segments breakouts |
|||
| International Healthcare Solutions · Operating Segments | 35,815 | 33,361 | +7.4% |
| U. S. Healthcare Solutions · Operating Segments | 78,253 | 60,882 | +28.5% |
Show — breakouts |
|||
| Depreciation & Amortization | 260,401 | 278,492 | -6.5% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 21,175 | 19,393 | +9.2% |
| Investing Activities | |||
| Capital Expenditures (Q) | — | — | — |
Show — breakouts |
|||
| Capital Expenditures | -119,376 | -105,893 | -12.7% |
| Payments To Acquire Businesses Net Of Cash Acquired (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Businesses Net Of Cash Acquired | -219,686 | -9,015 | -2336.9% |
| Proceeds From Sale Of Other Productive Assets (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Sale Of Other Productive Assets | 43,057 | — | — |
| Payments To Acquire Equity Method Investments (Q) | — | — | — |
Show — breakouts |
|||
| Payments To Acquire Equity Method Investments | -10,710 | -182,014 | +94.1% |
| Other Investing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Other Investing Activities | 7,400 | -11,303 | +165.5% |
| Net Cash from Investing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -299,315 | -343,039 | +12.7% |
| Financing Activities | |||
| Proceeds From Issuance Of Debt (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Issuance Of Debt | 107,720 | 1,806,028 | -94.0% |
| Repayments Of Long Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Repayments Of Long Term Debt | -131,709 | -44,950 | -193.0% |
| Proceeds From Lines Of Credit (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Lines Of Credit | 23,791,590 | 15,454,257 | +53.9% |
| Repayments Of Lines Of Credit (Q) | — | — | — |
Show — breakouts |
|||
| Repayments Of Lines Of Credit | -23,501,389 | -13,427,095 | -75.0% |
| Proceeds From Stock Options Exercised (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Stock Options Exercised | 7,598 | 8,108 | -6.3% |
| Payments Of Dividends Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Payments Of Dividends Common Stock | -126,516 | -110,888 | -14.1% |
| Tax Withholding for Share Compensation (Q) | — | — | — |
Show — breakouts |
|||
| Tax Withholding for Share Compensation | -98,151 | -73,963 | -32.7% |
| Proceeds From Payments For Other Financing Activities (Q) | — | — | — |
Show — breakouts |
|||
| Proceeds From Payments For Other Financing Activities | -5,939 | -16,876 | +64.8% |
| Net Cash from Financing (Q) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | 43,204 | 3,209,150 | -98.7% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations (Q) | — | — | — |
Show — breakouts |
|||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -24,576 | -50,235 | +51.1% |
| Net Change in Cash (Q) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | -2,585,856 | 97,094 | -2763.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1,808,693 | 3,394,974 | -46.7% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 27,155 | — | — |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.